Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A single ascending dose study of bapineuzumab in patients with Alzheimer disease.

A single ascending dose study of bapineuzumab in patients with Alzheimer disease. Alzheimer Dis Assoc Disord. 2010 Apr-Jun; 24(2):198-203.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.